APR02286G

antibody from Leading Biology
Targeting: TRAF3 CAP-1, CD40bp, CRAF1, LAP1, RNF118
Provider product page for APR02286G
Western blot
Immunocytochemistry
Immunohistochemistry

Antibody data

Product number
APR02286G - Provider product page
Provider
Leading Biology
Product name
TRAF3 Antibody (C-Terminus)
Antibody type
Polyclonal
Description
Regulates pathways leading to the activation of NF- kappa-B and MAP kinases, and plays a central role in the regulation of B-cell survival. Part of signaling pathways leading to the production of cytokines and interferon. Required for normal antibody isotype switching from IgM to IgG. Plays a role T-cell dependent immune responses. Plays a role in the regulation of antiviral responses. Is an essential constituent of several E3 ubiquitin-protein ligase complexes. May have E3 ubiquitin-protein ligase activity and promote 'Lys-63'-linked ubiquitination of target proteins. Inhibits activation of NF-kappa-B in response to LTBR stimulation. Inhibits TRAF2-mediated activation of NF-kappa- B. Down-regulates proteolytic processing of NFKB2, and thereby inhibits non-canonical activation of NF-kappa-B. Promotes ubiquitination and proteasomal degradation of MAP3K14.
Reactivity
Human, Mouse
Host
Rabbit
Storage
Store at +4°C short term. For long-term storage, aliquot and store at -20°C or below. Stable for 12 months at -20°C. Avoid repeated freeze-thaw cycles.
TRAF3 protein structure - APR02286G shown in red.